Promoter hypermethylation of IGFBP3 is an early event in prostate carcinogenesis

被引：0
|
作者：
Perrv, A.
Loftus, B.
Moroose, R.
Lynch, T.
Hollywood, D.
Watson, R. W. G.
Woodson, K.
Lawler, M.
机构：
[1] Trinity Coll Dublin, Dept Haematol, Acad Unit Clin & Mol Oncol, Dublin, Ireland
[2] Adelaide & Meath Inc, Natl Childrens Hosp, Dublin, Ireland
[3] Florida Hosp Canc Ctr, Orlando, FL USA
[4] St James Hosp, Dublin 8, Ireland
[5] Univ Coll Dublin, Dublin 2, Ireland
[6] Natl Canc Inst, Bethesda, MD USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2007年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(07)60670-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [31] IGFBP3 Colocalizes with and Regulates Hypocretin (Orexin)
    Honda, Makoto
    Eriksson, Krister S.
    Zhang, Shengwen
    Tanaka, Susumu
    Lin, Ling
    Salehi, Ahmad
    Hesla, Per Egil
    Maehlen, Jan
    Gaus, Stephanie E.
    Yanagisawa, Masashi
    Sakurai, Takeshi
    Taheri, Shahrad
    Tsuchiya, Kuniaki
    Honda, Yutaka
    Mignot, Emmanuel
    PLOS ONE, 2009, 4 (01):
  • [32] Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis
    Wong, Oscar Gee-Wan
    Huo, Zhen
    Siu, Michelle Kwan-Yee
    Zhang, HuiJuan
    Jiang, LiLi
    Wong, Ester Shuk-Ying
    Cheung, Annie Nga-Yin
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2010, 2010
  • [33] Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk:: The multiethnic cohort
    Cheng, Iona
    Penney, Kathryn L.
    Stram, Daniel O.
    Le Marchand, Loic
    Giorgi, Elena
    Haiman, Christopher A.
    Kolonel, Laurence N.
    Pike, Malcolm
    Hirschhorn, Joel
    Henderson, Brian E.
    Freedman, Matthew L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (10) : 1993 - 1997
  • [34] IGFBP3 promotes resistance to olaparib via modulating EGFR signaling in advanced prostate cancer
    Leslie, Amy R.
    Gao, Allen C.
    Lombard, Alan P.
    Ning, Shu
    CANCER RESEARCH, 2023, 83 (11)
  • [35] Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3
    Chen, Xuanrong
    Shao, Yi
    Wei, Wanqing
    Shen, Haishan
    Li, Yang
    Chen, Yutong
    Ma, Qianwang
    Li, Hanlin
    Yang, Zhao
    Niu, Yuanjie
    Shang, Zhiqun
    JOURNAL OF CANCER, 2021, 12 (24): : 7349 - 7357
  • [36] IGFBP3 promotes resistance to olaparib via modulating EGFR signaling in advanced prostate cancer
    Leslie, Amy R.
    Ning, Shu
    D'Abronzo, Leandro S.
    Armstrong, Cameron
    Sharifi, Masuda
    Schaaf, Zachary A.
    Lou, Wei
    Evans, Christopher P.
    Chen, Hong-Wu
    Lombard, Alan
    Gao, Allen C.
    CANCER RESEARCH, 2023, 83 (07)
  • [37] Frequent promoter hypermethylation and down regulation of BNIP3: An early event during gallbladder cancer progression
    Bharti, Amisha
    Kar, Amrita Ghosh
    Singh, Deepika
    Ansari, Mumtaz Ahmad
    Tewari, Mallika
    Narayan, Gopeshwar
    Singh, Sunita
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (09) : 1257 - 1263
  • [38] IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer
    Leslie, Amy R.
    Ning, Shu
    Armstrong, Cameron M.
    D'Abronzo, Leandro S.
    Sharifi, Masuda
    Schaaf, Zachary A.
    Lou, Wei
    Liu, Chengfei
    Evans, Christopher P.
    Lombard, Alan P.
    Gao, Allen C.
    ISCIENCE, 2024, 27 (02)
  • [39] Polymorphism in IGFBP3 gene is associated with prostate cancer risk: an updated meta-analysis
    Qie, Yunkai
    Nian, Xuewu
    Liu, Xuesen
    Hu, Hailong
    Zhang, Changwen
    Xie, Linguo
    Han, Ruifa
    Wu, Changli
    Xu, Yong
    ONCOTARGETS AND THERAPY, 2016, 9 : 4163 - 4171
  • [40] DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis
    Fujimoto, J
    Yasui, W
    Tahara, H
    Tahara, E
    Kudo, Y
    Yokozaki, H
    Tahara, E
    CANCER LETTERS, 2000, 149 (1-2) : 125 - 134
12345